The risk of recuring of intestinal cancer of our country is up to 50 Postoperative aid is imperative in treatment

The risk of recuring of intestinal cancer of our country is up to 50 Postoperative aid is imperative in treatment
The risk of recuring of intestinal cancer of our country is up to 50 Postoperative aid is imperative in treatment
On May 7, the one sponsored by Chinese Anti-Cancer Association, controlled the office to support in Ministry of Public Health " gather the love, the way where the also excellent Chinese anticancer of life hopes " Special patient educates and launches in Chengdu formally with the voluntary consulting activity intestinal cancer. Cloud of Rod of famous expert of the intestinal cancer field in this city, Yang Lie, Professor Zhao Xin and over one hundred stomaches intestinal cancer patient,etc. have participated in the activity. Come from institute belly associate professor of treatment of oncology department Rod's cloud professor of China's Western medicine and understand the cause of disease of intestinal cancer, develop and prevent and cure at the scene in detail. While assisting and treating after mentioning the skill, Professor Luo point out ��, issues of intestinal cancer must combine, treat and come on and drive the residual cancer cell out while being other while being postoperative, in order to reduce the risk of recuring. Still there are 50% of the risks of recuring after because of the surgery of intestinal cancer, the expert reminds the patient not to give up assisting and treating because of poisonous side effect. The patient can consider the target comes to improve security and validity to the oral chemotherapy medicine, such as wish Rhold,etc., malicious side effect relatively low, it depilate with bone marrow inhibiting the incidence from less than 5%. The common bad reaction can be relieved rapidly after medicines stopped usually, needn't be in hospital either. Each Rhold assist by chemotherapy make in order to wishing in the light of research reveal, large intestine it recurs that risk is expected to last 12% in the cancers, the death risk is reduced by 14%, the absolute value of survival rate can be improved by 3.0% in 5.


|